Rocket Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The firm's multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. 

CEO
Gaurav D. Shah
CEOGaurav D. Shah
Employees
202
Employees202
Headquarters
Cranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded
1999
Founded1999
Employees
202
Employees202

RCKT Key Statistics

Market cap
380.37M
Market cap380.37M
Price-Earnings ratio
-18.55
Price-Earnings ratio-18.55
Dividend yield
Dividend yield
Average volume
1.71M
Average volume1.71M
High today
$3.47
High today$3.47
Low today
$3.28
Low today$3.28
Open price
$3.33
Open price$3.33
Volume
800.81K
Volume800.81K
52 Week high
$5.45
52 Week high$5.45
52 Week low
$2.53
52 Week low$2.53

Stock Snapshot

The current Rocket Pharmaceuticals(RCKT) stock price is $3.47, with a market capitalization of 380.37M. The stock trades at a price-to-earnings (P/E) ratio of -18.55.

On 2026-08-14, Rocket Pharmaceuticals(RCKT) stock moved within a range of $3.28 to $3.47. With shares now at $3.47, the stock is trading +5.8% above its intraday low and -0.1% below the session's peak.

Trading volume for Rocket Pharmaceuticals(RCKT) stock has reached 800.81K, versus its average volume of 1.71M.

Over the past 52 weeks, Rocket Pharmaceuticals(RCKT) stock has traded between a high of $5.45 and a low of $2.53.

Over the past 52 weeks, Rocket Pharmaceuticals(RCKT) stock has traded between a high of $5.45 and a low of $2.53.

RCKT News

TipRanks 18h
Rocket Pharmaceuticals Executives Make Bold Moves With Fresh Insider Stock Sales

New insider activity at Rocket Pharmaceuticals ( (RCKT) ) has taken place on August 13, 2026. Claim 55% Off TipRanks Unlock powerful investing tools with TipRan...

Zacks 3d
Rocket Pharmaceuticals Q2 Earnings Rise Y/Y, Kresladi Launch in Focus - Zacks Investment Research

...

Rocket Pharmaceuticals Q2 Earnings Rise Y/Y, Kresladi Launch in Focus - Zacks Investment Research
TipRanks 4d
Rocket Pharmaceuticals reports Q2 EPS $1.08, consensus 35c

As of June 30, 2026, Rocket had cash, cash equivalents and investments of $283.7 million. Based on its current operating plan, Rocket expects its cash, cash equ...

Analyst ratings

47%

of 15 ratings
Buy
40%
Hold
46.7%
Sell
13.3%

People also own

Based on the portfolios of people who own RCKT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.